They also found that tumor-derived IL-4 increased the expression levels of antiapoptotic proteins and prevented cell death upon TRAIL exposure and chemotherapy in primary epithelial cancer cells from colon, breast, and lung carcinomas, while IL-4 blockade sensitized them [53]. The gene discussed is IL4; the disease is lung carcinoma.